You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
27 March 2024
Merck KGaA: Dr. Matthias Heinzel, buy
Merck KGaA: Peter Guenter, buy
25 January 2024
15 December 2023
13 December 2023
5 December 2023
Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide
27 November 2023
24 November 2023
22 November 2023
21 November 2023
15 November 2023
14 November 2023
13 November 2023
3 November 2023
25 October 2023
24 October 2023
23 October 2023
16 October 2023
27 September 2023
21 September 2023
18 September 2023
14 September 2023
11 September 2023
8 September 2023
5 September 2023
30 August 2023
29 August 2023
26
Apr 24
Annual General Meeting
15
May 24
Publication quarterly financial report (call-date Q1)
01
Aug 24
Publication half-yearly financial report
14
Nov 24
Publication quarterly financial report (call-date Q3)